48
Participants
Start Date
August 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
January 31, 2012
BPZE1
Individuals will be vaccinated once intranasally with the designated dose of BPZE1 Dose 2 x 0.1 mL (0.1 mL per nostril).
Placebo
Individuals will get placebo once intranasally. Dose 2 x 0.1 mL (0.1 mL per nostril).
Karolinska University Hospital, Solna
Collaborators (1)
European Union
OTHER
Swedish Institute for Infectious Disease Control
OTHER
Innogenetics
UNKNOWN
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV